One of the most breathtaking intersections of medicine and technology is 3D bioprinting, a process that uses living cells, growth factors, and biomaterials to create biological structures layer-by-layer. While it may sound like science fiction, this technology is rapidly advancing from laboratories into practical clinical applications, holding the promise to solve the critical shortage of donor organs and revolutionize surgical preparation and medical training. The most ambitious goal of bioprinting is the creation of functional human tissues and organs for transplantation. Researchers have already successfully printed simple tissues like skin, cartilage, and blood vessels. While printing a complex, solid organ like a heart or liver that is fully functional and can be transplanted remains a long-term challenge, progress is steady. This could eventually eliminate transplant waiting lists and the need for immunosuppressive drugs, as organs could be printed using a patient's own cells. In the near term, bioprinted tissues are being used for drug testing and disease modeling, providing a more accurate and ethical alternative to animal testing. Beyond organ creation, 3D printing is already making a significant impact in surgery today. Using standard medical imaging data like CT and MRI scans, surgeons can print accurate, patient-specific models of a patient's anatomy. A surgeon can hold a replica of a patient's heart with a tumor or a complex bone fracture before ever setting foot in the operating room. This allows for precise pre-operative planning, selection of the best surgical approach, and even practicing the procedure, which reduces operative time and improves patient outcomes. Custom-printed surgical guides and implants, tailored to a patient's unique anatomy, are also becoming commonplace. Despite the exciting progress, significant hurdles remain. The technology for vascularization—creating the intricate network of blood vessels needed to sustain thick tissues—is a major obstacle. Regulatory pathways for approving bioprinted organs for human use are still being defined. The high cost of bioprinters and bio-inks is also a barrier. Nevertheless, 3D bioprinting represents a paradigm shift towards truly personalized medicine, where treatments and even replacement body parts are custom-made for the individual patient, heralding a new era in regenerative medicine.

• Articals